179 related articles for article (PubMed ID: 36394355)
1. Systematic review with meta-analysis: Branched-chain amino acid supplementation in liver disease.
van Dijk AM; Bruins Slot AS; Portincasa P; Siegerink SN; Chargi N; Verstraete CJR; de Bruijne J; Vleggaar FP; van Erpecum KJ
Eur J Clin Invest; 2023 Mar; 53(3):e13909. PubMed ID: 36394355
[TBL] [Abstract][Full Text] [Related]
2. Branched-chain amino acids for people with hepatic encephalopathy.
Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
[TBL] [Abstract][Full Text] [Related]
3. Branched-chain amino acids for people with hepatic encephalopathy.
Gluud LL; Dam G; Les I; Marchesini G; Borre M; Aagaard NK; Vilstrup H
Cochrane Database Syst Rev; 2017 May; 5(5):CD001939. PubMed ID: 28518283
[TBL] [Abstract][Full Text] [Related]
4. Branched-chain amino acids for people with hepatic encephalopathy.
Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
Cochrane Database Syst Rev; 2015 Sep; (9):CD001939. PubMed ID: 26377410
[TBL] [Abstract][Full Text] [Related]
5. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
Hayaishi S; Chung H; Kudo M; Ishikawa E; Takita M; Ueda T; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ueshima K
Dig Dis; 2011; 29(3):326-32. PubMed ID: 21829025
[TBL] [Abstract][Full Text] [Related]
6. Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: A randomized trial.
Nojiri S; Fujiwara K; Shinkai N; Iio E; Joh T
Nutrition; 2017 Jan; 33():20-27. PubMed ID: 27908546
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of oral branched-chain amino acid supplementation in patients undergoing interventions for hepatocellular carcinoma: a meta-analysis.
Chen L; Chen Y; Wang X; Li H; Zhang H; Gong J; Shen S; Yin W; Hu H
Nutr J; 2015 Jul; 14():67. PubMed ID: 26155840
[TBL] [Abstract][Full Text] [Related]
8. [Effect of oral administration of branched-chain amino acids supplementation on the mortality of patients with hepatocellular carcinoma: a meta-analysis].
Xue WX; Yang F; Duan JJ; Sun JB; Peng H
Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(47):3793-3800. PubMed ID: 33379845
[No Abstract] [Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Effects of branched-chain amino acids supplementation on patients undergoing hepatic intervention: a meta-analysis of randomised controlled trials.
Hsu YM; Kuan HC; Chen YA; Chiu CW; Chen PC; Tam KW
Br J Nutr; 2024 Jan; 131(2):276-285. PubMed ID: 37642137
[TBL] [Abstract][Full Text] [Related]
11. Effect of dietary branched chain amino acids on liver related mortality: Results from a large cohort of North American patients with advanced HCV infection.
Yu L; Paski SC; Dodge J; Bambha K; Biggins SW; Ioannou GN
PLoS One; 2023; 18(4):e0284739. PubMed ID: 37098004
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of branched chain amino acids supplementation in liver cirrhosis: A systematic review and meta-analysis.
Konstantis G; Pourzitaki C; Chourdakis M; Kitsikidou E; Germanidis G
Clin Nutr; 2022 Jun; 41(6):1171-1190. PubMed ID: 35500317
[TBL] [Abstract][Full Text] [Related]
13. Impairment of innate immune responses in cirrhotic patients and treatment by branched-chain amino acids.
Nakamura I
World J Gastroenterol; 2014 Jun; 20(23):7298-305. PubMed ID: 24966600
[TBL] [Abstract][Full Text] [Related]
14. Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis.
Kawaguchi T; Shiraishi K; Ito T; Suzuki K; Koreeda C; Ohtake T; Iwasa M; Tokumoto Y; Endo R; Kawamura NH; Shiraki M; Habu D; Tsuruta S; Miwa Y; Kawaguchi A; Kakuma T; Sakai H; Kawada N; Hanai T; Takahashi S; Kato A; Onji M; Takei Y; Kohgo Y; Seki T; Tamano M; Katayama K; Mine T; Sata M; Moriwaki H; Suzuki K
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1012-8.e1. PubMed ID: 24036055
[TBL] [Abstract][Full Text] [Related]
15. Branched-chain amino acids supplementation improves liver frailty index in frail compensated cirrhotic patients: a randomized controlled trial.
Siramolpiwat S; Limthanetkul N; Pornthisarn B; Vilaichone RK; Chonprasertsuk S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N
BMC Gastroenterol; 2023 May; 23(1):154. PubMed ID: 37189033
[TBL] [Abstract][Full Text] [Related]
16. Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
Kawaguchi T; Izumi N; Charlton MR; Sata M
Hepatology; 2011 Sep; 54(3):1063-70. PubMed ID: 21563202
[TBL] [Abstract][Full Text] [Related]
17. Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study.
Park JG; Tak WY; Park SY; Kweon YO; Jang SY; Lee YR; Bae SH; Jang JY; Kim DY; Lee JS; Suk KT; Kim IH; Lee HJ; Chung WJ; Jang BK; Suh JI; Heo J; Lee WK
Medicine (Baltimore); 2017 Jun; 96(24):e6580. PubMed ID: 28614215
[TBL] [Abstract][Full Text] [Related]
18. Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study.
Park JG; Tak WY; Park SY; Kweon YO; Chung WJ; Jang BK; Bae SH; Lee HJ; Jang JY; Suk KT; Oh MJ; Heo J; Woo HY; Jang SY; Lee YR; Lee JS; Kim DY; Kim SH; Suh JI; Kim IH; Kang MK; Lee WK
Nutrients; 2020 May; 12(5):. PubMed ID: 32429077
[TBL] [Abstract][Full Text] [Related]
19. Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model.
Takegoshi K; Honda M; Okada H; Takabatake R; Matsuzawa-Nagata N; Campbell JS; Nishikawa M; Shimakami T; Shirasaki T; Sakai Y; Yamashita T; Takamura T; Tanaka T; Kaneko S
Oncotarget; 2017 Mar; 8(11):18191-18205. PubMed ID: 28212548
[TBL] [Abstract][Full Text] [Related]
20. Branched-chain amino acid enriched supplements as therapy for liver disease.
Charlton M
J Nutr; 2006 Jan; 136(1 Suppl):295S-8S. PubMed ID: 16365102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
